Sökresultat - "anti‐PD‐1 antibody"

Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors

Kubo, Toshio^{Aff1, Aff2}, Kato, Hironari, Horiguchi, Shigeru, Kozuki, Toshiyuki, Asagi, Akinori, Yoshida, Michihiro, Udono, Heiichiro, Kiura, Katsuyuki, Hotta, Katsuyuki^{Aff1, Aff6, IDs10147025027862_cor1}

Complete response to pembrolizumab in mismatch repair-deficient urothelial carcinoma with local recurrence and recurrent upper tract urothelial carcinoma: a case report

Shiraishi, Koichi, Shiota, Masaki^{Aff1, IDs1369102500774x_cor1}, Fukuchi, Genshiro^{Aff1, Aff2}, Tanegashima, Tokiyoshi, Tsukahara, Shigehiro, Mutaguchi, Jun, Kobayashi, Satoshi, Matsumoto, Takashi, Oda, Yoshinao, Eto, Masatoshi

Exploring predictive biomarkers of efficacy and survival with nivolumab treatment for unresectable/recurrent esophageal squamous cell carcinoma

Nakai, Shigeto, Makino, Tomoki^{Aff1, IDs1038802501120z_cor1}, Momose, Kota, Yamashita, Kotaro, Tanaka, Koji, Miyata, Hiroshi, Yamamoto, Sachiko, Motoori, Masaaki, Kimura, Yutaka, Kawabata, Ryohei, Hirao, Motohiro, Matsuyama, Jin, Akamaru, Yusuke, Morihara, Hitomi, Ueyama, Azumi, Kurokawa, Yukinori, Morii, Eiichi, Wada, Hisashi^{Aff1, Aff10}, Eguchi, Hidetoshi, Doki, Yuichiro

Lenvatinib enhances antitumor immunity of anti-PD-1 antibody

Kato, Yu^{Aff1, IDs10147025027215_cor1}

Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model

Hiroyuki Inoue, Takayuki Hamasaki, Kazuhiko Inoue, Akira Nakao, Noriyuki Ebi, Hirofumi Minomo, Ichiro Nagata, Masaki Fujita, Naoto Horai

electronic resource

Visa

PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab

Kadoi, Ryohei, Yoshida, Taichi, Noto, Mai, Toyoshima, Aya, Fujii, Sino^{Aff1, Aff3}, Fukuda, Koji, Shimazu, Kazuhiro, Taguchi, Daiki, Shinozaki, Hanae, Kodama, Naoki, Kono, Michihiro, Nanjyo, Hiroshi, Shibata, Hiroyuki^{Aff1, IDs13691024006764_cor13}

Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer

Zongfeng Hu, Yixiao Li, Jianshuai Yang, Jiajia Liu, Hua Zhou, Chunyang Sun, Chao Tian, Chengyang Zhu, Mingxia Shao, Shengrun Wang, Lijun Wei, Min Liu, Shuzhen Li, Jinyu Wang, Haitian Xu, Wei Zhu, Xiaopeng Li, Jingfeng Li

electronic resource

Visa

Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma

Liu, Jiacheng^{Aff1, Aff2}, Bai, Yaowei^{Aff1, Aff2}, Liu, Xiaoming^{Aff1, Aff2}, Zhou, Binqian, Sun, Peng, Wang, Yingliang^{Aff1, Aff2}, Ju, Shuguang^{Aff1, Aff2}, Zhou, Chen^{Aff1, Aff2}, Wang, Chaoyang^{Aff1, Aff2}, Yao, Wei^{Aff1, Aff2}, Yang, Huihui, Jiang, Xin, Yang, Lian^{Aff1, Aff2, IDs4159802472907w_cor13}, Wang, Dongyuan^{Aff7, Aff8, IDs4159802472907w_cor14}, Zheng, Chuansheng^{Aff1, Aff2, IDs4159802472907w_cor15}

GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy

Kim, Hae-Mi, Kim, Kyoung-Jin, Lee, Kwanghyun, Yoon, Myeong Jin, Choih, Jenny^{Aff1, Aff2}, Hong, Tae-Joon, Cho, Eun Ji, Jung, Hak-Jun, Kim, Jayoung, Park, Ji Soo^{Aff3, Aff4}, Na, Hye Young^{Aff3, Aff5}, Heo, Yong-Seok, Park, Chae Gyu^{Aff1, Aff3}, Park, Heungrok, Han, Sungho^{Aff1, Aff2}, Bae, Donggoo^{Aff1, IDs1286502400609z_cor16}

Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients

Zhang, Jingjing, Wang, Lei, Zhang, Shasha, Cao, Ruijie, Zhao, Yufei, Zhao, Yue, Song, Yanrong, Guo, Zhanjun^{Aff1, IDs1288502411999z_cor8}

Tumorous IRE1α facilitates CD8⁺T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma

Yang, Yuqi, Wang, Sijia, Wang, Xiang-xu, Guo, Sen, Wang, Huina, Shi, Qiong, Tian, Yangzi, Wang, Hao, Zhao, Tao, Zhang, Hengxiang, Zhang, Baolu, Gao, Tianwen, Li, Chunying^{Aff1, IDs12964024014708_cor13}, Yi, Xiuli^{Aff1, IDs12964024014708_cor14}, Guo, Weinan^{Aff1, IDs12964024014708_cor15}

Efficacy and safety of sintilimab combined with trastuzumab and chemotherapy in HER2-positive advanced gastric or gastroesophageal junction cancer

Zeyu Liu, Aina Liu, Ming Li, Jinyu Xiang, Guohua Yu, Ping Sun

electronic resource

Visa; Visa

GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis

Dušica Ristić, Thomas Bärnthaler, Eva Gruden, Melanie Kienzl, Laura Danner, Karolina Herceg, Arailym Sarsembayeva, Julia Kargl, Rudolf Schicho

electronic resource

Visa; Visa

Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody

Chang, Qimeng ^{a, b, c, 1}, Mao, Huarong ^{a, b, c, 1}, Feng, Jinfeng ^{a, b, c}, Rao, Longhua ^{a, b, c}, Tang, Weiguo ^{a, b, c}, Zhang, Ziping ^{a, b, c}, Hu, Zhiqiu ^{a, b, c, ⁎}

Adjuvant Therapy in Acral Melanoma: A Systematic Review

Zhu Z, Liu M, Zhang H, Zheng H, Li J

electronic resource

Visa; Visa

Sequential pH/GSH-responsive stealth nanoparticles for co-delivery of anti-PD-1 antibody and paclitaxel to enhance chemoimmunotherapy of lung cancer

Li, Kan, Gui, Shengbin, Wang, Ningning, Li, Xiao, Zhao, Chunqin, Liu, Mingyu ^⁎⁎, Zhang, Zhen ^⁎

Rocaglamide promotes infiltration and differentiation of T cells and coordinates with PD-1 inhibitor to overcome checkpoint resistance in multiple tumor models

Luo, Jiaojiao, Ng, Wanyi, Liu, Yangli, Wang, Lixin, Gong, Chenyuan, Zhou, Yufu, Fang, Cheng, Zhu, Shiguo^{Aff1, IDs00262024037065_cor8}, Yao, Chao^{Aff1, IDs00262024037065_cor9}

Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic review

Philippe Saiag, Lucien Lahmi, Elisa Funck-Brentano

electronic resource

Visa; Visa

LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy

Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang

electronic resource

Visa

Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study

Yiwen Hu, Linlin Zhang, Qinghua Qi, Shanshan Ren, Simeng Wang, Lanling Yang, Juan Zhang, Yuanyuan Liu, Xiaoxiao Li, Xiguo Cai, Shaobo Duan, Lianzhong Zhang

electronic resource

Visa; Visa